A leading cancer centre has described ANGLE 's proprietary imaging technique for the detection of cancer as " demonstrating significant advantages " in detecting circulating tumour cells ( CTCs ) in the bloodstream versus other technologies , saying its technique uses isolated cells at a very high purity , and captures a broad range of cells , to ensure a detailed diagnosis . So - called liquid biopsies to diagnose cancer have long been a goal of biotechnology researchers , as treating cancer earlier gives doctors a better chance to treat it .
A leading cancer centre has described ANGLE's Parsotix liquid biopsy for the detection of cancer as "demonstrating significant advantages" in detecting circulating tumour cells (CTCs) in the bloodstream versus other technologies, saying its technique delivers isolated CTCs at a very high purity, and captures a broad range of cells, to enable a detailed diagnosis. So-called liquid biopsies to diagnose cancer have long been a goal of biotechnology companies, as detecting cancer earlier gives doctors a better chance to treat it.